162 related articles for article (PubMed ID: 14528534)
1. Antibody response to influenza immunization in patients with systemic lupus erythematosus.
Mercado U
J Rheumatol; 2003 Oct; 30(10):2295; author reply 2295-6. PubMed ID: 14528534
[No Abstract] [Full Text] [Related]
2. Specific antibody response after influenza immunization in systemic lupus erythematosus.
Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
[TBL] [Abstract][Full Text] [Related]
4. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
[TBL] [Abstract][Full Text] [Related]
5. Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Arthritis Rheum; 2009 Aug; 60(8):2438-47. PubMed ID: 19644961
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity.
Del Porto F; Laganà B; Biselli R; Donatelli I; Campitelli L; Nisini R; Cardelli P; Rossi F; D'Amelio R
Vaccine; 2006 Apr; 24(16):3217-23. PubMed ID: 16466833
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination of patients with systemic lupus erythematosus.
Mercado U; Acosta H; Avendaño L
Rev Invest Clin; 2004; 56(1):16-20. PubMed ID: 15144037
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal immunization in patients with systemic lupus erythematosus treated with immunosuppressives.
Lipnick RN; Karsh J; Stahl NI; Blackwelder WC; Schiffman G; Klippel JH
J Rheumatol; 1985 Dec; 12(6):1118-21. PubMed ID: 4093916
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
Stojanovich L
Clin Dev Immunol; 2006; 13(2-4):373-5. PubMed ID: 17162380
[TBL] [Abstract][Full Text] [Related]
10. Influenza vaccination in systemic lupus erythematosus: safe and protective?
Holvast B; Huckriede A; Kallenberg CG; Bijl M
Autoimmun Rev; 2007 Apr; 6(5):300-5. PubMed ID: 17412302
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity to change of the MOS SF-36 quality of life assessment questionnaire in patients with systemic lupus erythematosus taking immunosuppressive therapy.
Rood MJ; Borggreve SE; Huizinga TW
J Rheumatol; 2000 Aug; 27(8):2057-9. PubMed ID: 10955362
[No Abstract] [Full Text] [Related]
12. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
[TBL] [Abstract][Full Text] [Related]
13. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
Purice S; Ghelerter L; Matei I; Brunazian G
Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
[No Abstract] [Full Text] [Related]
14. [Immunosuppressive therapy of systemic lupus erythematosus].
Miescher PA; Lambert PH
Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
[No Abstract] [Full Text] [Related]
15. [Systemic veupus erythematosus. Possibilities and limitations of treatment].
Kahn MF
Nouv Presse Med; 1972 Mar; 1(13):849-51. PubMed ID: 4537003
[No Abstract] [Full Text] [Related]
16. Vaccination and autoimmune rheumatic diseases.
Conti F; Rezai S; Valesini G
Autoimmun Rev; 2008 Dec; 8(2):124-8. PubMed ID: 18700175
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy in systemic lupus erythematosus.
Russell AS; Bretscher PA
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():194-8. PubMed ID: 3302253
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccination of patients with systemic lupus erythematosus: safety and immunogenecity issues.
Abu-Shakra M; Press J; Buskila D; Sukenik S
Autoimmun Rev; 2007 Sep; 6(8):543-6. PubMed ID: 17854746
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of specific anti-influenza antibody production by cultured lymphocytes from patients with systemic lupus erythematosus following influenza immunization.
Mitchell DM; Fitzharris P; Knight RA; Schild GC; Snaith ML
Clin Exp Immunol; 1982 Aug; 49(2):290-6. PubMed ID: 7127906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
